The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

NCT00385697 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

554

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: Teplizumab
DRUG: Placebo

Sponsor

MacroGenics

Collaborators

[object Object]